Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer, Karo Bio AB team up in the area of autoimmune disorders

Executive Summary

Pfizer Inc. has partnered with Karo Bio AB (nuclear receptor therapeutic protein targets) for the discovery and development of small-molecule retinoic acid-related orphan receptor (ROR-gamma) modulators for autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies